The 5 Medical Tests That Could Save Your Life (And When to Get Them)

Published: March 22, 2026  ·  Last updated: April 28, 2026

Most preventable deaths in the United States come from a short list of conditions — heart disease, stroke, several common cancers, type 2 diabetes — each of which has a screening test that catches the problem early enough to dramatically improve outcomes. The tests aren't experimental, aren't expensive under most insurance, and aren't time-consuming. The reason they get missed isn't usually patient resistance. It's that no one tracks the cumulative list and the years go by.

Five tests, run on the schedule below, cover the highest-yield slice of preventive medicine for adult Americans. They don't replace a primary care relationship and they don't cover everyone's individual risk factors. They are the floor — the minimum baseline that every reasonably healthy adult should be hitting on schedule, and the right starting point for the conversation about anything else.

Test 1: Blood Pressure (Every Visit, Starting at 18)

According to the U.S. Preventive Services Task Force, blood pressure screening for adults 18 and older is a Grade A recommendation — the strongest evidence rating the panel issues. High blood pressure is silent in the early stages, common (more than 120 million American adults have it), and the leading modifiable risk factor for heart disease and stroke.

The test takes 30 seconds. Adults with normal readings need it every 3 to 5 years up to age 40 and annually thereafter. Anyone with elevated readings, family history, or other cardiovascular risk needs more frequent monitoring. The threshold for diagnosis is below what many people remember: under 120/80 is now considered normal, 120-129 over less than 80 is elevated, and 130/80 and above is the new hypertension threshold per the 2017 ACC/AHA guidelines.

Treatment is well-established and largely lifestyle plus inexpensive medications when needed. The cost of catching hypertension at age 45 instead of age 65 is the difference between two decades of arterial protection and two decades of accumulating damage.

Test 2: Colorectal Cancer Screening (Starting at 45)

The USPSTF lowered the recommended starting age for colorectal cancer screening to 45 in 2021 in response to rising rates of early-onset cases. The full menu of acceptable approaches includes colonoscopy every 10 years, annual fecal immunochemical test (FIT), stool DNA testing every 1-3 years, CT colonography every 5 years, or flexible sigmoidoscopy with stool testing.

For most people, the choice between colonoscopy and FIT is the practical decision. Colonoscopy is the most thorough — it can both detect and remove polyps in the same session — but requires bowel prep and sedation. FIT is a once-yearly stool test you can do at home, with very low burden but lower sensitivity for polyps that haven't bled. Both reduce colorectal cancer mortality. The best test is the one you'll actually do.

Continue screening through age 75 as a routine recommendation, with selective screening from 76 to 85 based on overall health and prior results. Family history of colorectal cancer or polyps shifts the start age earlier and the interval shorter — discuss specifics with your physician.

Test 3: Lipid Panel (Every 4 to 6 Years, More Often With Risk Factors)

The lipid panel measures total cholesterol, LDL, HDL, and triglycerides. The USPSTF gives statin therapy for primary prevention a Grade B recommendation for adults aged 40-75 with one or more cardiovascular risk factors and a 10-year cardiovascular risk of 7.5% or higher. Knowing your lipid numbers is a prerequisite for that risk calculation.

Standard adult guidance is a baseline lipid panel by age 35 (men) or 45 (women), repeated every 4 to 6 years if normal, more frequently if abnormal or with diabetes, hypertension, or family history of premature heart disease. The test requires a simple blood draw; most adults can have it done with their next routine office visit.

The treatment landscape has shifted: high LDL no longer means automatic statin therapy in everyone. The decision integrates LDL, age, sex, smoking status, blood pressure, and diabetes status into a 10-year risk score. The test is the input; the decision belongs in a discussion with a clinician.

Test 4: Diabetes and Prediabetes Screening (Starting at 35)

Per the USPSTF, all adults aged 35 to 70 who are overweight or obese should be screened for prediabetes and type 2 diabetes. The most common screen is hemoglobin A1c — a single blood test that reflects average blood glucose over the prior 3 months. Fasting plasma glucose and oral glucose tolerance testing are alternatives.

The numbers to know: A1c below 5.7% is normal, 5.7-6.4% is prediabetes, 6.5% or above is diabetes. The prediabetes range is the actionable window — lifestyle interventions (a 5-7% body weight reduction, ~150 minutes of weekly moderate exercise) can prevent or delay progression to diabetes by roughly 58% in trials. Once full diabetes is established, the conversation shifts to medication and complications management.

Repeat the test every 3 years if normal. More frequently if prediabetic or with strong risk factors. The screening is cheap, the implications are large, and the early-window interventions actually work.

Test 5: Cancer Screening Specific to Sex and Risk

According to Harvard Health, the most consequential sex-specific cancer screening tests are mammography for women and shared-decision-making about prostate-specific antigen (PSA) testing for men. The USPSTF recommends biennial mammograms for women aged 40-74. Some societies recommend annual screening starting at 40; women should discuss the right schedule with their clinician.

For men, PSA testing is more nuanced. The USPSTF recommends shared decision-making for men aged 55-69, weighing the modest mortality benefit against the substantial risk of overdiagnosis and overtreatment. The right answer for many men is "discuss it with your doctor at 50, decide based on your family history and life expectancy, and don't make this a default automatic test."

Cervical cancer screening (Pap smear and/or HPV test) is recommended for women aged 21 to 65, with intervals depending on test type. Lung cancer screening with low-dose CT is recommended for current or former heavy smokers aged 50-80. Skin self-exams and clinical exams aren't formally graded but are a sensible part of any annual encounter, especially for fair-skinned people with significant sun exposure.

To your health,

Ageless CoachTM

Age Strong. Live Long.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reading this article does not create a provider-patient relationship. Always consult your physician or qualified healthcare provider before making changes to your diet, exercise, or health routine. Ageless Coach is not liable for any actions taken based on this information.